BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37531800)

  • 1. Response to growth hormone therapy in ring chromosome 15: Review and evidence from a new case on possible beneficial effect in neurodevelopment.
    Wannes S; El Ahmer I; Rjiba K; Jemmali N; Abdallah HH; Haj RB; Achour A; Bouzidi H; Saad A; Mougou S; Mahjoub B
    Growth Horm IGF Res; 2023 Aug; 71():101550. PubMed ID: 37531800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The phenotype and rhGH treatment response of ring Chromosome 15 Syndrome: Case report and literature review.
    Chen M; Ke X; Liang H; Gong F; Yang H; Wang L; Duan L; Pan H; Cao D; Zhu H
    Mol Genet Genomic Med; 2021 Dec; 9(12):e1842. PubMed ID: 34747577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
    Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics and Long-Term Recombinant Human Growth Hormone Treatment of 18q- Syndrome: A Case Report and Literature Review.
    Liu S; Chen M; Yang H; Chen S; Wang L; Duan L; Zhu H; Pan H
    Front Endocrinol (Lausanne); 2021; 12():776835. PubMed ID: 34956087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good response to long-term therapy with growth hormone in a patient with 9p trisomy syndrome: A case report and review of the literature.
    Canton AP; Nishi MY; Furuya TK; Roela RA; Jorge AA
    Am J Med Genet A; 2016 Apr; 170A(4):1046-9. PubMed ID: 26689153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting bone age maturation during 3 years of growth hormone treatment in patients with idiopathic growth hormone deficiency and idiopathic short stature: Analysis of data from the LG growth study.
    Kang MJ; Kim EY; Shim YS; Jeong HR; Lee HJ; Yang S; Hwang IT
    Medicine (Baltimore); 2019 Apr; 98(14):e14962. PubMed ID: 30946320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature.
    Liu HJ; Wang LH; Chen L
    Adv Ther; 2019 Sep; 36(9):2374-2383. PubMed ID: 31301056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful long-term growth hormone therapy in a girl with haploinsufficiency of the insulin-like growth factor-I receptor due to a terminal 15q26.2->qter deletion detected by multiplex ligation probe amplification.
    Walenkamp MJ; de Muinck Keizer-Schrama SM; de Mos M; Kalf ME; van Duyvenvoorde HA; Boot AM; Kant SG; White SJ; Losekoot M; Den Dunnen JT; Karperien M; Wit JM
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2421-5. PubMed ID: 18349070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good growth response to growth hormone treatment in the ring chromosome 15 syndrome.
    Nuutinen M; Kouvalainen K; Knip M
    J Med Genet; 1995 Jun; 32(6):486-7. PubMed ID: 7545237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired GH secretion in patients with SHOX deficiency and efficacy of recombinant human GH therapy.
    Iughetti L; Vannelli S; Street ME; Pirazzoli P; Bertelloni S; Radetti G; Capone L; Stasiowska B; Mazzanti L; Gastaldi R; Maggio MC; Predieri B
    Horm Res Paediatr; 2012; 78(5-6):279-87. PubMed ID: 23208451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth Hormone Treatment for Short Stature in the USA, Germany and France: 15 Years of Surveillance in the Genetics and Neuroendocrinology of Short-Stature International Study (GeNeSIS).
    Pfäffle R; Land C; Schönau E; Holterhus PM; Ross JL; Piras de Oliveira C; Child CJ; Benabbad I; Jia N; Jung H; Blum WF
    Horm Res Paediatr; 2018; 90(3):169-180. PubMed ID: 30199857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of growth hormone treatment on height in children with idiopathic short stature.
    Jeong HR; Shim YS; Lee HS; Hwang JS
    J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):629-33. PubMed ID: 24810558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term response to growth hormone therapy in a patient with short stature caused by a novel heterozygous mutation in NPR2.
    Vasques GA; Hisado-Oliva A; Funari MF; Lerario AM; Quedas EP; Solberg P; Heath KE; Jorge AA
    J Pediatr Endocrinol Metab; 2017 Jan; 30(1):111-116. PubMed ID: 27941173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone therapy in Silver Russell syndrome: 5 years experience of the Australian and New Zealand Growth database (OZGROW).
    Rakover Y; Dietsch S; Ambler GR; Chock C; Thomsett M; Cowell CT
    Eur J Pediatr; 1996 Oct; 155(10):851-7. PubMed ID: 8891553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant growth hormone therapy for prepubertal children with idiopathic short stature in Korea: a phase III randomized trial.
    Kim J; Suh BK; Ko CW; Lee KH; Shin CH; Hwang JS; Kim HS; Chung WY; Kim CJ; Han HS; Kwon NY; Cho SY; Yoo HW; Jin DK
    J Endocrinol Invest; 2018 Apr; 41(4):475-483. PubMed ID: 29103133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone treatment of idiopathic short stature: analysis of the database from KIGS, the Kabi Pharmacia International Growth Study.
    Ranke MB; Lindberg A
    Acta Paediatr Suppl; 1994 Dec; 406():18-23; discussion 24. PubMed ID: 7734807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced human growth hormone (hGH) bioactivity without a defect of the GH-1 gene in three patients with rhGH responsive growth failure.
    Binder G; Benz MR; Elmlinger M; Pflaum CD; Strasburger CJ; Ranke MB
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):89-95. PubMed ID: 10468970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.